Acutaas Chemicals schedules April 30, 2026 board meeting to approve Q4 and FY26 audited financial results.
Board will consider recommending a final dividend for FY 2025-26, subject to shareholder approval.
Trading window for designated persons remains closed until May 4, 2026, following insider trading regulations.